Maravai LifeSciences Holdings, Inc. (MRVI)
| Market Cap | 1.48B |
| Revenue (ttm) | 274.10M |
| Net Income (ttm) | -131.04M |
| Shares Out | 132.83M |
| EPS (ttm) | -0.99 |
| PE Ratio | n/a |
| Forward PE | 30.40 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,187,724 |
| Open | 11.23 |
| Previous Close | 11.32 |
| Day's Range | 10.78 - 11.46 |
| 52-Week Range | 4.52 - 14.88 |
| Beta | 0.03 |
| Analysts | Buy |
| Price Target | 11.44 (+2.83%) |
| Earnings Date | May 8, 2024 |
About MRVI
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases worldwide. The company's products address the key phases of biopharmaceutical development and include nucleic acids for diagnostic and therapeutic applications, antibody-based products to detect impurities during the production of biopharmaceutical products, and products to detect the expression of proteins in tissues of various species. It operates in tw... [Read more]
Financial Performance
Financial StatementsAnalyst Forecast
According to 10 analysts, the average rating for MRVI stock is "Buy." The 12-month stock price forecast is $11.44, which is an increase of 2.83% from the latest price.
News
TriLink BioTechnologies collaborates with Johns Hopkins University to establish a new RNA Innovation Center
SAN DIEGO--(BUSINESS WIRE)--TriLink BioTechnologies (TriLink®), a Maravai™ LifeSciences company (NASDAQ: MRVI) and global provider of life science reagents and services, is collaborating with the John...
Maravai LifeSciences Announces May and June 2024 Investor Conference Schedule
SAN DIEGO, May 09, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to pa...
Maravai LifeSciences Reports First Quarter 2024 Financial Results
Continued Focus on Product Portfolio Expansion, Market Leadership and Scientific Innovation Continued Focus on Product Portfolio Expansion, Market Leadership and Scientific Innovation
TriLink BioTechnologies® and Lonza Enter into Non-exclusive License and Supply Agreement for CleanCap® mRNA Capping Technology
SAN DIEGO--(BUSINESS WIRE)--TriLink BioTechnologies® and Lonza Enter into Non-exclusive License and Supply Agreement for CleanCap® mRNA Capping Technology.
TriLink BioTechnologies® Announces New San Diego Facility for Late Phase mRNA Drug Substance Production
SAN DIEGO--(BUSINESS WIRE)--TriLink BioTechnologies® Announces New San Diego Facility for Late Phase mRNA Drug Substance Production.
Maravai LifeSciences To Host Earnings Conference Call on Wednesday, May 8, 2024
SAN DIEGO, April 10, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans ...
Maravai LifeSciences Announces March 2024 Investor Conference Schedule
SAN DIEGO, March 12, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to ...
Maravai LifeSciences Reports Fourth Quarter and Full Year 2023 Financial Results
Continued Focus on Expanding Product Portfolio, Market Leadership and Innovation Continued Focus on Expanding Product Portfolio, Market Leadership and Innovation
Maravai LifeSciences To Host Earnings Conference Call on Thursday, February 22, 2024
SAN DIEGO, Jan. 29, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans t...
Maravai LifeSciences Announces November 2023 Investor Conference Schedule
SAN DIEGO, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to p...
Maravai LifeSciences To Host Earnings Conference Call on Tuesday, November 7, 2023
SAN DIEGO, Oct. 17, 2023 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans t...
Maravai LifeSciences Hosts 2023 Investor R&D Day
Highlights include the company's strong foundation for growth, focus on innovation and attractive long-term outlook Highlights include the company's strong foundation for growth, focus on innovation a...
Maravai LifeSciences Chief Innovation Officer Kate Broderick Named to 2023 PharmaVoice 100
SAN DIEGO, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today announced ...
Maravai LifeSciences to Host 2023 Investor R&D Day
SAN DIEGO, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovator...
Cygnus Technologies Receives 2023 R&D 100 Award for MockV® RVLP Kit
LELAND, N.C., Aug. 23, 2023 (GLOBE NEWSWIRE) -- Cygnus Technologies, part of Maravai LifeSciences (Maravai) (NASDAQ: MRVI), the leading product and services provider for the detection and characteriza...
Maravai LifeSciences Announces August 2023 Investor Conference Schedule
SAN DIEGO, Aug. 09, 2023 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to p...
Maravai LifeSciences Reports Second Quarter 2023 Financial Results
Continued Focus on Expanding Product Portfolio, Market Leadership and Scientific Innovation Continued Focus on Expanding Product Portfolio, Market Leadership and Scientific Innovation
Maravai LifeSciences Announces Completion of Planned CEO Leadership Transition
GlobeNewswire window.initGradientEffect = function () { } document.addEventListener('DOMContentLoaded', function () { const extendedTableZoomElements = document.querySelectorAll('.extended-table-zoom'...
Maravai LifeSciences To Host Earnings Conference Call on Monday, August 7, 2023
SAN DIEGO, July 24, 2023 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators...
Maravai LifeSciences Announces Appointment of New Director to the Board
SAN DIEGO, July 20, 2023 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (“Maravai” or the “Company”) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and...
Maravai LifeSciences To Host Earnings Conference Call on Monday, May 8, 2023
SAN DIEGO, April 17, 2023 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans ...
Maravai LifeSciences Releases 2022 Environmental, Social and Governance (ESG) Report
- Highlights progress across five priority areas focused on building a foundation for sustainable growth.
Maravai LifeSciences Announces March 2023 Investor Conference Schedule
SAN DIEGO, March 08, 2023 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to ...
Maravai LifeSciences Reports Fourth Quarter and Full Year 2022 Financial Results
Base business revenues, excluding COVID-19 related CleanCap® revenues, were up 67% in the fourth quarter and up 17% for the full year
Maravai LifeSciences to Host Earnings Conference Call on Wednesday, February 22, 2023
SAN DIEGO, Feb. 01, 2023 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans t...